NICE approves first new drug for Giant Cell Arteritis
NICE, the National Institute for Health and Clinical Excellence, has approved the use of Tocilizumab for cases of Giant Cell Arteritis. There has not been a new drug for this disease since steroids were first used 70 years ago. Thousands of patients have had no